- Home
- ATXS vs RWT Comparison
ATXS vs RWT Comparison
Compare ATXS & RWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATXS | RWT |
|---|---|---|
| Founded | 2008 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 722.1M | 693.0M |
| IPO Year | 2015 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ATXS | RWT |
|---|---|---|
| Price | $12.95 | $5.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $24.33 | $7.00 |
| AVG Volume (30 Days) | ★ 1.3M | 1.1M |
| Earning Date | 11-12-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 12.86% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $706,000.00 | ★ $120,897,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $46.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.56 | $4.68 |
| 52 Week High | $13.29 | $7.19 |
Technical Indicators
Market Signals| Indicator | ATXS | RWT |
|---|---|---|
| Relative Strength Index (RSI) | 65.10 | 57.47 |
| Support Level | $12.70 | $5.45 |
| Resistance Level | $13.29 | $5.70 |
| Average True Range (ATR) | 0.22 | 0.13 |
| MACD | -0.06 | 0.03 |
| Stochastic Oscillator | 65.33 | 82.14 |
Price Performance
Historical ComparisonAbout ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.